DR. WILLIAM FRANK NOVOTNY, M.D.
Osteopathic Medicine at Miranda Ave, Palo Alto, CA
License number
California G71175
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
2
3801 Miranda Ave, Palo Alto, CA 94304
95 Riordan Pl, Menlo Park, CA 94025
95 Riordan Pl, Menlo Park, CA 94025
Phone
(650) 493-5000
Professional information
William Frank Novotny, Palo Alto CA
Specialties:
Internist
Address:
3801 Miranda Ave, Palo Alto, CA 94304
Education:
University of California San Diego, School of Medicine - Doctor of Medicine
Barnes-Jewish Hospital - Fellowship - Hematology
Mount Sinai Hospital, The - Residency - Internal Medicine
Barnes-Jewish Hospital - Fellowship - Hematology
Mount Sinai Hospital, The - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Gene Expression Profile Algorithm And Test For Determining Prognosis Of Prostate Cancer
US Patent:
2013019, Aug 1, 2013
Filed:
Jan 28, 2013
Appl. No.:
13/752199
Inventors:
Mark Lee - Los Altos Hills CA, US
William Novotny - Menlo Park CA, US
Tara Maddala - Sunnyvale CA, US
Michael Crager - Menlo Park CA, US
Diana Cherbavaz - San Francisco CA, US
Robert J. Pelham - Belmont CA, US
Carl L. Millward - Burlingame CA, US
Dejan Knezevic - Palo Alto CA, US
William Novotny - Menlo Park CA, US
Tara Maddala - Sunnyvale CA, US
Michael Crager - Menlo Park CA, US
Diana Cherbavaz - San Francisco CA, US
Robert J. Pelham - Belmont CA, US
Carl L. Millward - Burlingame CA, US
Dejan Knezevic - Palo Alto CA, US
Assignee:
GENOMIC HEALTH, INC. - Redwood City CA
International Classification:
G06F 19/20, C12Q 1/68
US Classification:
435 611, 435 612, 702 19
Abstract:
The present invention provides algorithm-based molecular assays that involve measurement of expression levels of genes, or their co-expressed genes, from a biological sample obtained from a prostate cancer patient. The genes may be grouped into functional gene subsets for calculating a quantitative score useful to predict a likelihood of a clinical outcome for a prostate cancer patient.
Treatment With Anti-Vegf Antibodies
US Patent:
2008027, Nov 13, 2008
Filed:
May 27, 2008
Appl. No.:
12/127733
Inventors:
Gwendolyn Fyfe - San Francisco CA, US
Eric Holmgren - Palo Alto CA, US
Robert D. Mass - Mill Valley CA, US
William Novotny - Menlo Park CA, US
Eric Holmgren - Palo Alto CA, US
Robert D. Mass - Mill Valley CA, US
William Novotny - Menlo Park CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
A61K 39/395, A61P 35/00
US Classification:
4241451
Abstract:
This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.